Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.

De novo experimental drug discovery is an expensive and time-consuming task. It requires the identification of drug-target interactions (DTIs) towards targets of biological interest, either to inhibit or enhance a specific molecular function. Dedicated computational models for protein simulation and...

Full description

Bibliographic Details
Main Authors: Edgar D Coelho, Joel P Arrais, José Luís Oliveira
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-11-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC5125559?pdf=render
id doaj-bfb3edf7638d485491957321539f7386
record_format Article
spelling doaj-bfb3edf7638d485491957321539f73862020-11-25T02:12:16ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582016-11-011211e100521910.1371/journal.pcbi.1005219Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.Edgar D CoelhoJoel P ArraisJosé Luís OliveiraDe novo experimental drug discovery is an expensive and time-consuming task. It requires the identification of drug-target interactions (DTIs) towards targets of biological interest, either to inhibit or enhance a specific molecular function. Dedicated computational models for protein simulation and DTI prediction are crucial for speed and to reduce the costs associated with DTI identification. In this paper we present a computational pipeline that enables the discovery of putative leads for drug repositioning that can be applied to any microbial proteome, as long as the interactome of interest is at least partially known. Network metrics calculated for the interactome of the bacterial organism of interest were used to identify putative drug-targets. Then, a random forest classification model for DTI prediction was constructed using known DTI data from publicly available databases, resulting in an area under the ROC curve of 0.91 for classification of out-of-sampling data. A drug-target network was created by combining 3,081 unique ligands and the expected ten best drug targets. This network was used to predict new DTIs and to calculate the probability of the positive class, allowing the scoring of the predicted instances. Molecular docking experiments were performed on the best scoring DTI pairs and the results were compared with those of the same ligands with their original targets. The results obtained suggest that the proposed pipeline can be used in the identification of new leads for drug repositioning. The proposed classification model is available at http://bioinformatics.ua.pt/software/dtipred/.http://europepmc.org/articles/PMC5125559?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Edgar D Coelho
Joel P Arrais
José Luís Oliveira
spellingShingle Edgar D Coelho
Joel P Arrais
José Luís Oliveira
Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
PLoS Computational Biology
author_facet Edgar D Coelho
Joel P Arrais
José Luís Oliveira
author_sort Edgar D Coelho
title Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
title_short Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
title_full Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
title_fullStr Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
title_full_unstemmed Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction.
title_sort computational discovery of putative leads for drug repositioning through drug-target interaction prediction.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2016-11-01
description De novo experimental drug discovery is an expensive and time-consuming task. It requires the identification of drug-target interactions (DTIs) towards targets of biological interest, either to inhibit or enhance a specific molecular function. Dedicated computational models for protein simulation and DTI prediction are crucial for speed and to reduce the costs associated with DTI identification. In this paper we present a computational pipeline that enables the discovery of putative leads for drug repositioning that can be applied to any microbial proteome, as long as the interactome of interest is at least partially known. Network metrics calculated for the interactome of the bacterial organism of interest were used to identify putative drug-targets. Then, a random forest classification model for DTI prediction was constructed using known DTI data from publicly available databases, resulting in an area under the ROC curve of 0.91 for classification of out-of-sampling data. A drug-target network was created by combining 3,081 unique ligands and the expected ten best drug targets. This network was used to predict new DTIs and to calculate the probability of the positive class, allowing the scoring of the predicted instances. Molecular docking experiments were performed on the best scoring DTI pairs and the results were compared with those of the same ligands with their original targets. The results obtained suggest that the proposed pipeline can be used in the identification of new leads for drug repositioning. The proposed classification model is available at http://bioinformatics.ua.pt/software/dtipred/.
url http://europepmc.org/articles/PMC5125559?pdf=render
work_keys_str_mv AT edgardcoelho computationaldiscoveryofputativeleadsfordrugrepositioningthroughdrugtargetinteractionprediction
AT joelparrais computationaldiscoveryofputativeleadsfordrugrepositioningthroughdrugtargetinteractionprediction
AT joseluisoliveira computationaldiscoveryofputativeleadsfordrugrepositioningthroughdrugtargetinteractionprediction
_version_ 1724910407139721216